Levels of expression and immunogenicity of attenuated Salmonella enterica serovar typhimurium strains expressing Escherichia coli mutant heat- labile enterotoxin

Infection and Immunity

Volumn 66, Issue 1, 1998, Pages 224-231

  Covone, M Giuseppina ^a   Brocchi, Marcelo ^a,b   Palla, Emanuela ^a   Da Silveira, W Dias ^b   Rappuoli, Ring ^a   Galeotti, Cesira L ^a  

^a CHIRON VACCINES   (Italy)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI ENTEROTOXIN;

ANTIGEN EXPRESSION; ARTICLE; DNA INTEGRATION; ESCHERICHIA COLI; IMMUNE RESPONSE; IMMUNOGENICITY; PRIORITY JOURNAL; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM;

ESCHERICHIA COLI; SALMONELLA ENTERICA;

EID: 0031965593     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.1.224-231.1998     Document Type: Article

References (40)

1. Bost, K. L., and J. D. Clements. 1995. In vivo induction of interleukin-12 mRNA expression after oral immunization with Salmonella dublin or the B subunit of Escherichia coli heat-labile enterotoxin. Infect. Immun. 63:1076-1083.
2. Brocchi, M., M. G. Covone, E. Palla, and C. L. Galeotti. Unpublished data.
3. Cárdenas, L., and J. D. Clements. 1993. Stability, immunogenicity and expression of foreign antigens in bacterial vaccine vectors. Vaccine 11:126-135.
4. Cárdenas, L., U. Dasgupta, and J. D. Clements. 1994. Influence of strain viability and antigen dose on the use of attenuated mutants of Salmonella as vaccine carriers. Vaccine 12:833-840.
5. Chatfield, S. N., N. Fairweather, I. Charles, D. Pickard, M. Levine, D. Hone, M. Posada, R. A. Strugnell, and G. Dougan. 1992. Construction of a genetically defined Salmonella typhi Ty2 aroA, aroC mutant for the engineering of a candidate oral typhoid-tetanus vaccine. Vaccine 10:53-60.
6. Curtiss, R., III, and S. M. Kelly. 1987. Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic. Infect. Immun. 55:3035-3043.
7. Curtiss, R., III, S. M. Kelly, P. A. Gulig, and K. Nakayama. 1989. Selective delivery of antigens by recombinant bacteria. Curr. Top. Microbiol. Immunol. 146:35-19.
8. Curtiss, R., III. 1990. Attenuated Salmonella strains as live vectors for the expression of foreign antigens, p. 161-188. In G. C. Woodrow and M. M. Levine (ed.), New generation vaccines. Marcel Dekker, Inc., New York, N.Y.
9. Dallas, W. S., and S. Falkow. 1980. Amino acid sequence homology between cholera toxin and Escherichia coli heat-labile toxin. Nature 288:499-501.
10. Di Tommaso, A., G. Saletti, M. Pizza, R. Rappuoli, G. Dougan, S. Abrignani, G. Douce, and M. T. De Magistris. 1996. Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant. Infect. Immun. 64:974-979.
11. Dougan, G. 1994. The molecular basis for the virulence of bacterial pathogens: implications for oral vaccine development. Microbiology 140:215-224.
12. Dougan, G., S. N. Chatfield, D. Pickard, D. O'Caliaghan, and D. Maskell. 1988. Construction and characterization of Salmonella vaccine strains harbouring mutations in two different aro genes. J. Infect. Dis. 158:1329-1335.
13. Galan, J. E., K. Nakayama, and R. Curtiss III. 1990. Cloning and characterization of the asd gene of Salmonella typhimurium: use in stable maintenance of recombinant plasmids in Salmonella typhimurium. Gene 94:29-35.
14. Gentry-Weeks, C. R., A.-L. Hultsch, S. M. Kelly, J. M. Keith, and R. Curtiss III. 1992. Cloning and sequencing of a gene encoding a 21-kilodalton outer membrane protein from Bordetella avium and expression of the gene in Salmonella typhimurium. J. Bacteriol. 174:7729-7742.
15. Gyles, C. L., and D. A. Barnum. 1969. A heat-labile enterotoxin from strains of E. coli enteropathogenic for pigs. J. Infect. Dis. 120:419-426.
16. Hofstra, H., and B. J. Witholt. 1984. Kinetics of synthesis, processing and membrane transport of heat-labile enterotoxin, a periplasmic protein in E. coli. J. Biol. Chem. 259:15182-15187.
17. Hoiseth, S. K., and B. A. D. Stocker. 1981. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 291:238-239.
18. Hone, D., R. Morona, S. Attridge, and J. Hackett. 1987. Construction of a defined galE mutant of Salmonella for vaccine use. J. Infect. Dis. 156:167-174.
19. Hone, D., A. M. Harris, S. Chatfield, G. Dougan, and M. M. Levine. 1991. Construction of genetically-defined double aro mutants of Salmonella typhi. Vaccine 9:810-816.
20. Karem, K. L., S. Chatfield, N. Kuklin, and B. T. Rouse. 1995. Differential induction of carrier antigen-specific immunity by Salmonella typhimurium live-vaccine strains after single mucosal or intravenous immunization of BALB/c mice. Infect. Immun. 63:4557-4563.
21. Magagnoli, C., R. Manetti, M. R. Fontana, V. Giannelli, M. M. Giuliani, R. Rappuoli, and M. Pizza. 1996. Mutations in the A subunit affect yield, stability, and protease sensitivity of nontoxic derivatives of heat-labile enterotoxin. Infect. Immun. 64:5434-5438.
22. Masked, D. J., K. J. Sweeney, D. O'Callaghan, C. E. Hormaeche, F. Y. Liew, and G. Dougan. 1987. Salmonella typhimurium aroA mutants as carriers of the Escherichia coli heat-labile enterotoxin B subunit to the murine secretory and systemic immune system. Microb. Pathog. 2:211-221.
23. Miller, S. I., W. P. Loomis, C Alpuche-Aranda, I. Behlau, and E. Hohmann. 1993. The PhoP virulence regulon and live oral Salmonella vaccines. Vaccine 11:122-125.
24. + expression-cloning vector: stable maintenance and high level expression of cloned genes in a Salmonella vaccine strain. Bio/Technology 6:693-697.
25. Oyston, P. C. F., E. D. Williamson, S. E. C. Leary, S. M. Eley, K. F. Griffin, and R. W. Titball. 1995. Immunization with live recombinant Salmonella typhimurium aroA producing F1 antigen protects against plague. Infect. Immun. 63:563-568.
26. Packard, D., J. Li, M. Roberts, D. Maskell, D. Hone, M. M. Levine, G. Dougan, and S. Chatfield. 1994. Characterization of defined ompR mutants of Salmonella typhi: ompR is involved in the regulation of Vi polysaccharide expression. Infect. Immun. 62:3984-3993.
27. Pizza, M., M. Domenighini, W. Hol, V. Giannelli, M. R. Fontana, M. M. Giuliani, C. Magagnoli, S. Peppoloni, R. Manetti, and R. Rappuoli. 1994. Probing the structure-activity relationship of Escherichia coli LT-A by site-directed mutagenesis. Mol. Microbiol. 14:51-60.
28. Pizza, M., M. R. Fontana, M. M. Giuliani, M. Domenighini, C. Magagnoli, V. Giannelli, D. Nucci, W. Hol, R. Manetti, and R. Rappuoli. 1994. A genetically detoxified derivative of heat-labile Escherichia coli enterotoxin induces neutralizing antibodies against the A subunit. J. Exp. Med. 180:2147-2153.
29. Redman, T. K., C. C. Harmon, R. L. Lallone, and S. M. Michalek. 1995. Oral immunization with recombinant Salmonella typhimurium expressing surface protein antigen A of Streptococcus sohrinus: dose response and induction of protective humoral responses in rats. Infect. Immun. 63:2004-2011.
30. Rossolini, G. M., P. Muscas, A. Chiesurin, and G. Satta. 1993. Molecular cloning and expression in Escherichia coli of the Salmonella typhi gene cluster coding for type 1 fimbriac, p. 408-412. In F. Cabello et al. (ed.), The biology of Salmonella. Plenum Publishing Co., New York, N.Y.
31. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
32. Sanderson, K. E., A. Hessel. and K. E. Rudd. 1995. Genetic map of Salmonella typhimurium, edition VIII. Microbiol. Rev. 59:241-303.
33. Schödel, F., S. M. Kelly, D. L. Peterson, D. R. Milich, and R. Curtiss III. 1994. Hybrid hepatitis B virus core-pre-S proteins synthesized in avirulent Salmonella typhimurium and Salmonella typhi for oral vaccination. Infect. Immun. 62:1669-1676.
34. Smith, H. W., and S. Halls. 1967. Escherichia coli enterotoxin. J. Pathol. Bacteriol. 93:531-543.
35. Spicer, E. K., W. M. Kavanaugh, W. S. Dallas, S. Falkow, W. H. Konigsberg, and D. Shafer. 1981. Sequence homologies between A subunits of E. coli and V. cholera enterotoxin. Proc. Natl. Acad. Sci. USA 78:50-54.
36. Staats, H. F., R. J. Jackson, M. Marinaro, I. Takahashi, H. Kiyono, and J. R. McGhee. 1994. Mucosal immunity to infection with implications for vaccine development. Curr. Opin. Immunol. 6:572-583.
37. Tacket, C. O., D. M. Hone, R. Curtiss III, S. M. Kelly, G. Losonsky, L. Guers, A. M. Harris, R. Edelman, and M. M. Levine. 1992. Comparison of the safety and immunogenicity of ΔaroC ΔaroD and Δcya Δcrp Salmonella typhi strains in adult volunteers. Infect. Immun. 60:536-541.
38. Tsai, C. M., and C. E. Frash. 1983. A sensitive stain for detecting lipopolysaccharides in polyacrylamide gels. Anal. Biochem. 119:115-119.
39. Walker, R. I. 1994. New strategies for using mucosal vaccination to achieve more effective immunization. Vaccine 12:387-400.
40. Zhang, T., and S. L. Stanley, 1996. Oral immunization with an attenuated vaccine strain of Salmonella typhimurium expressing the serine-rich Entamoeba histolytica protein induces an antiamebic immune response and protects gerbils from amebic liver abscess. Infect. Immun. 64:1526-1531.